Literature DB >> 17235564

Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer.

Guangying Qi1, Ikuko Ogawa, Yasusei Kudo, Mutsumi Miyauchi, B S M S Siriwardena, Fumio Shimamoto, Masaaki Tatsuka, Takashi Takata.   

Abstract

Aurora-B kinase is a chromosomal passenger protein and is essential for chromosome segregation and cytokinesis. Aurora-B overexpression in various cancer cells induces chromosomal number instability to produce multinuclearity and relates to metastasis. Here, we examined the expression of Aurora-B in oral squamous cell carcinoma (OSCC) to elucidate the relationship between Aurora-B expression and clinico-pathological findings by immunohistochemistry. Aurora-B expression was observed in normal oral squamous epithelia and OSCC cases, but the number of positive cells was significantly higher in OSCC than in normal squamous epithelium (p < 0.01). The labeling index of Aurora-B was significantly correlated with lymph node metastasis (p < 0.01) and histological grades of differentiation (p < 0.01). We also compared Aurora-B expression with Ki-67 expression and a positive correlation was found (p < 0.0001). Moreover, Aurora-B expression is significantly more frequent in multinuclear tumor cells than in total tumor cells. In summary, we found that Aurora-B expression was well correlated with cell proliferation, induction of multinuclear cells, histological differentiation, and metastasis in OSCC. These findings suggest that Aurora-B may be involved in tumor progression and that Aurora-B can be a new diagnostic and therapeutic target for OSCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235564     DOI: 10.1007/s00428-006-0360-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  The aurora B kinase AIR-2 regulates kinetochores during mitosis and is required for separation of homologous Chromosomes during meiosis.

Authors:  Susanne Kaitna; Pawel Pasierbek; Michael Jantsch; Josef Loidl; Michael Glotzer
Journal:  Curr Biol       Date:  2002-05-14       Impact factor: 10.834

2.  Aurora B -TACC1 protein complex in cytokinesis.

Authors:  Bénédicte Delaval; Alexia Ferrand; Nathalie Conte; Christian Larroque; Danièle Hernandez-Verdun; Claude Prigent; Daniel Birnbaum
Journal:  Oncogene       Date:  2004-06-03       Impact factor: 9.867

3.  Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation.

Authors:  Akifumi Kanda; Hidehiko Kawai; Shiho Suto; Shojiro Kitajima; Sunao Sato; Takashi Takata; Masaaki Tatsuka
Journal:  Oncogene       Date:  2005-11-10       Impact factor: 9.867

4.  Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells.

Authors:  R R Adams; D M Eckley; P Vagnarelli; S P Wheatley; D L Gerloff; A M Mackay; P A Svingen; S H Kaufmann; W C Earnshaw
Journal:  Chromosoma       Date:  2001-05       Impact factor: 4.316

5.  Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation.

Authors:  Margaret A Bolton; Weijie Lan; Shannon E Powers; Mark L McCleland; Jian Kuang; P Todd Stukenberg
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

6.  Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation.

Authors:  Rosanna Sorrentino; Silvana Libertini; Pier Lorenzo Pallante; Giancarlo Troncone; Lucio Palombini; Vassilios Bavetsias; Daniela Spalletti-Cernia; Paolo Laccetti; Spiros Linardopoulos; Paolo Chieffi; Alfredo Fusco; Giuseppe Portella
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

7.  Targeting Aurora kinases for the treatment of prostate cancer.

Authors:  Edmund Chun Yu Lee; Anna Frolov; Rile Li; Gustavo Ayala; Norman M Greenberg
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

8.  Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis.

Authors:  R Giet; D M Glover
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

9.  Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation.

Authors:  R R Adams; H Maiato; W C Earnshaw; M Carmena
Journal:  J Cell Biol       Date:  2001-05-14       Impact factor: 10.539

10.  Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle.

Authors:  Reto Gassmann; Ana Carvalho; Alexander J Henzing; Sandrine Ruchaud; Damien F Hudson; Reiko Honda; Erich A Nigg; Dietlind L Gerloff; William C Earnshaw
Journal:  J Cell Biol       Date:  2004-07-12       Impact factor: 10.539

View more
  41 in total

Review 1.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

2.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors:  O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

3.  Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies.

Authors:  Guillermo Garcia-Manero; Raoul Tibes; Tapan Kadia; Hagop Kantarjian; Martha Arellano; Emily A Knight; Hao Xiong; Qin Qin; Wijith Munasinghe; Lisa Roberts-Rapp; Peter Ansell; Daniel H Albert; Brian Oliver; Mark D McKee; Justin L Ricker; Hanna Jean Khoury
Journal:  Invest New Drugs       Date:  2015-05-02       Impact factor: 3.850

4.  Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas.

Authors:  Fahima Sijare; Anna-Lena Geißler; Christiane D Fichter; Sonja P Hergeth; Lioudmila Bogatyreva; Dieter Hauschke; Robert Schneider; Martin Werner; Silke Lassmann
Journal:  Virchows Arch       Date:  2015-02-14       Impact factor: 4.064

5.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

Review 6.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

7.  Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.

Authors:  Yi-Jen Chen; Chun-Ming Chen; Nae-Fang Twu; Ming-Shyen Yen; Chiung-Ru Lai; Hua-Hsi Wu; Peng-Hui Wang; Chiou-Chung Yuan
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

8.  Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.

Authors:  E Burum-Auensen; P M DeAngelis; A R Schjølberg; J Røislien; O Mjåland; O P F Clausen
Journal:  Cell Prolif       Date:  2008-08       Impact factor: 6.831

9.  The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma.

Authors:  Lkhagva-Ochir Tovuu; Tohru Utsunomiya; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Yusuke Arakawa; Hiroki Mori; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Yu Saito; Shinichiro Yamada; Michihito Asanoma; Mitsuo Shimada
Journal:  Int J Clin Oncol       Date:  2013-07-27       Impact factor: 3.402

10.  High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan.

Authors:  Jen-Hao Chen; Kun-Tu Yeh; Yu-Min Yang; Jan-Gowth Chang; Huey-Er Lee; Shih-Ya Hung
Journal:  Med Oncol       Date:  2013-03-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.